China SXT Pharmaceuticals, Inc. (SXTC) › Shareholders' EquityChina SXT Pharmaceuticals, Inc. (SXTC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: $742.8K2017: $1.85M2018: $3.29M2019: $11.11M2020: $9.40M2021: $15.96M2022: $16.08M2023: $14.69M2024: $13.93M2025: $15.44M$15.44M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$15.44M+10.8%2024$13.93M-5.2%2023$14.69M-8.7%2022$16.08M+0.8%2021$15.96M+69.8%2020$9.40M-15.4%2019$11.11M+238.1%2018$3.29M+77.4%2017$1.85M+149.4%2016$742.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share